• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物番泻苷B通过抑制SARS-CoV-2核衣壳蛋白的RNA结合活性来破坏其液-液相分离。

Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity.

作者信息

Zhang Da-Wei, Xu Xiao-Shuang, Xie Liangxu, Xu Lei, Fu Zhiguo, Li Yimin, Xu Xiaojun

机构信息

Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, China.

Department of Orthopedics, Changzhou Hospital of Traditional Chinese Medicine, Changzhou, China.

出版信息

J Enzyme Inhib Med Chem. 2025 Dec;40(1):2501743. doi: 10.1080/14756366.2025.2501743. Epub 2025 May 15.

DOI:10.1080/14756366.2025.2501743
PMID:40371698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082725/
Abstract

The nucleocapsid protein (NP) of SARS-CoV-2, an RNA-binding protein, is capable of undergoing liquid-liquid phase separation (LLPS) during viral infection, which plays a crucial role in virus assembly, replication, and immune regulation. In this study, we developed a homogeneous time-resolved fluorescence (HTRF) method for identifying inhibitors of the SARS-CoV-2 NP-RNA interaction. Using this HTRF-based approach, we identified two natural products, sennoside A and sennoside B, as effective blockers of this interaction. Bio-layer interferometry assays confirmed that both sennosides directly bind to the NP, with binding sites located within the C-terminal domain. Additionally, fluorescence recovery after photobleaching (FRAP) experiments revealed that sennoside B significantly inhibited RNA-induced LLPS of the NP, while sennoside A displayed comparatively weaker activity. Thus, the developed HTRF-based assay is a valuable tool for identifying novel compounds that disrupt the RNA-binding activity and LLPS of the SARS-CoV-2 NP. Our findings may facilitate the development of antiviral drugs targeting SARS-CoV-2 NP.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的核衣壳蛋白(NP)是一种RNA结合蛋白,在病毒感染期间能够发生液-液相分离(LLPS),这在病毒组装、复制和免疫调节中起着关键作用。在本研究中,我们开发了一种用于鉴定SARS-CoV-2 NP-RNA相互作用抑制剂的均相时间分辨荧光(HTRF)方法。使用这种基于HTRF的方法,我们鉴定出两种天然产物,番泻苷A和番泻苷B,它们是这种相互作用的有效阻断剂。生物层干涉术分析证实,这两种番泻苷均直接与NP结合,结合位点位于C末端结构域内。此外,光漂白后荧光恢复(FRAP)实验表明,番泻苷B显著抑制NP的RNA诱导的LLPS,而番泻苷A的活性相对较弱。因此,所开发的基于HTRF的检测方法是鉴定破坏SARS-CoV-2 NP的RNA结合活性和LLPS的新型化合物的有价值工具。我们的研究结果可能有助于开发针对SARS-CoV-2 NP的抗病毒药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/d257d1773615/IENZ_A_2501743_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/81bc56615619/IENZ_A_2501743_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/3d376793efa0/IENZ_A_2501743_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/bdd361808392/IENZ_A_2501743_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/76e1f8f063ff/IENZ_A_2501743_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/d257d1773615/IENZ_A_2501743_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/81bc56615619/IENZ_A_2501743_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/3d376793efa0/IENZ_A_2501743_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/bdd361808392/IENZ_A_2501743_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/76e1f8f063ff/IENZ_A_2501743_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47b1/12082725/d257d1773615/IENZ_A_2501743_F0005_C.jpg

相似文献

1
Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity.天然产物番泻苷B通过抑制SARS-CoV-2核衣壳蛋白的RNA结合活性来破坏其液-液相分离。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2501743. doi: 10.1080/14756366.2025.2501743. Epub 2025 May 15.
2
Unveiling potential inhibitors targeting the nucleocapsid protein of SARS-CoV-2: Structural insights into their binding sites.揭示针对 SARS-CoV-2 核衣壳蛋白的潜在抑制剂:对其结合位点的结构见解。
Int J Biol Macromol. 2024 Jul;273(Pt 2):133167. doi: 10.1016/j.ijbiomac.2024.133167. Epub 2024 Jun 15.
3
Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the replication of SARS-CoV-2 strains.靶向核衣壳的液-液相分离可广泛抑制SARS-CoV-2毒株的复制。
Biochem Biophys Res Commun. 2025 Apr 5;756:151594. doi: 10.1016/j.bbrc.2025.151594. Epub 2025 Mar 6.
4
Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.新型冠状病毒核衣壳蛋白相与富含 RNA 的聚合酶相分离形成凝聚物。
Nat Commun. 2020 Nov 27;11(1):6041. doi: 10.1038/s41467-020-19843-1.
5
Phosphorylation in the Ser/Arg-rich region of the nucleocapsid of SARS-CoV-2 regulates phase separation by inhibiting self-association of a distant helix.SARS-CoV-2 核衣壳的丝氨酸/精氨酸丰富区的磷酸化通过抑制远距离螺旋的自缔合来调节相分离。
J Biol Chem. 2024 Jun;300(6):107354. doi: 10.1016/j.jbc.2024.107354. Epub 2024 May 7.
6
Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.基因组 RNA 元件驱动 SARS-CoV-2 核衣壳的相分离。
Mol Cell. 2020 Dec 17;80(6):1078-1091.e6. doi: 10.1016/j.molcel.2020.11.041. Epub 2020 Nov 27.
7
Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组RNA 5'近端转录本与核衣壳蛋白之间结合特征的表征
RNA Biol. 2025 Dec;22(1):1-16. doi: 10.1080/15476286.2025.2471643. Epub 2025 Mar 12.
8
ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain.ATP 双相调节 SARS-CoV-2 核衣壳蛋白的液-液相分离,并特异性结合其 RNA 结合结构域。
Biochem Biophys Res Commun. 2021 Feb 19;541:50-55. doi: 10.1016/j.bbrc.2021.01.018. Epub 2021 Jan 14.
9
GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein.GCG 通过破坏其核衣壳蛋白的液相凝聚来抑制 SARS-CoV-2 的复制。
Nat Commun. 2021 Apr 9;12(1):2114. doi: 10.1038/s41467-021-22297-8.
10
Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein.基于结构的虚拟筛选以及针对人类冠状病毒核衣壳蛋白抑制剂发现的实验验证
Mol Biosyst. 2016 Jan;12(1):59-66. doi: 10.1039/c5mb00582e. Epub 2015 Nov 6.

本文引用的文献

1
Unveiling potential inhibitors targeting the nucleocapsid protein of SARS-CoV-2: Structural insights into their binding sites.揭示针对 SARS-CoV-2 核衣壳蛋白的潜在抑制剂:对其结合位点的结构见解。
Int J Biol Macromol. 2024 Jul;273(Pt 2):133167. doi: 10.1016/j.ijbiomac.2024.133167. Epub 2024 Jun 15.
2
SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery.严重急性呼吸综合征冠状病毒 2 核衣壳蛋白是抗病毒药物研发的潜在治疗靶点。
Microbiol Spectr. 2023 Jun 15;11(3):e0118623. doi: 10.1128/spectrum.01186-23. Epub 2023 May 18.
3
Suramin Disturbs the Association of the N-Terminal Domain of SARS-CoV-2 Nucleocapsid Protein with RNA.
苏拉明扰乱 SARS-CoV-2 核衣壳蛋白 N 端结构域与 RNA 的结合。
Molecules. 2023 Mar 10;28(6):2534. doi: 10.3390/molecules28062534.
4
Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2.结构解析核衣壳蛋白与 SARS-CoV-2 的非结构蛋白 3 相互作用导致核糖核蛋白复合物解离
Commun Biol. 2023 Feb 18;6(1):193. doi: 10.1038/s42003-023-04570-2.
5
Inhibition of SARS-CoV-2 nucleocapsid protein-RNA interaction by guanosine oligomeric RNA.寡聚鸟苷 RNA 抑制 SARS-CoV-2 核衣壳蛋白-RNA 相互作用。
J Biochem. 2023 May 29;173(6):447-457. doi: 10.1093/jb/mvad008.
6
ATP and nucleic acids competitively modulate LLPS of the SARS-CoV2 nucleocapsid protein.ATP 和核酸竞争性调节 SARS-CoV2 核衣壳蛋白的液-液相分离。
Commun Biol. 2023 Jan 21;6(1):80. doi: 10.1038/s42003-023-04480-3.
7
Discovery and structural characterization of chicoric acid as a SARS-CoV-2 nucleocapsid protein ligand and RNA binding disruptor.发现并结构表征绿原酸作为 SARS-CoV-2 核衣壳蛋白配体和 RNA 结合破坏剂。
Sci Rep. 2022 Nov 2;12(1):18500. doi: 10.1038/s41598-022-22576-4.
8
Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein.基于对严重急性呼吸综合征冠状病毒2核衣壳蛋白N端结构域和C端结构域的结构洞察进行抗病毒药物设计。
Sci Bull (Beijing). 2022 Nov 30;67(22):2327-2335. doi: 10.1016/j.scib.2022.10.021. Epub 2022 Oct 27.
9
Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein.醋酸阿比特龙通过干扰结构核衣壳蛋白来减弱新型冠状病毒的复制。
Biomol Ther (Seoul). 2022 Sep 1;30(5):427-434. doi: 10.4062/biomolther.2022.037. Epub 2022 May 13.
10
Phase separation by the SARS-CoV-2 nucleocapsid protein: Consensus and open questions.新冠病毒核衣壳蛋白介导的相分离:共识与待解决问题。
J Biol Chem. 2022 Mar;298(3):101677. doi: 10.1016/j.jbc.2022.101677. Epub 2022 Feb 4.